• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME SYNVISC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME SYNVISC Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Muscular Rigidity (1968); Swelling (2091); Reaction (2414)
Event Type  Injury  
Event Description
Pt has been on synvisc for 11 years and had no adverse drug event but for the most recent series, pt experienced severe leg swelling and knees could not bend at joint.She had to apply ice packs for a few weeks in order for the swelling to resolve.Md thinks it's an allergic reaction.Md is considering switching her to a different hyaluronic and derivative.Dose or amount: 16 mg.Frequency: once a week for 3 weeks into left knee.Route: ia.Dates of use: (b)(6) 2008 to (b)(6) 2017.Diagnosis or reason for use: m17.12 osteoarthritis of left knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
SYNVISC
Manufacturer (Section D)
GENZYME
MDR Report Key6621412
MDR Text Key77192919
Report NumberMW5070227
Device Sequence Number1
Product Code MOZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 06/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-